MRI in the diagnosis of pediatric multiple sclerosis

被引:104
作者
Callen, D. J. A. [1 ]
Shroff, M. M. [2 ]
Branson, H. M. [2 ]
Lotze, T. [5 ]
Li, D. K. [6 ]
Stephens, D. [4 ]
Banwell, B. L. [3 ]
机构
[1] McMaster Univ, Dept Pediat, Div Pediat Neurol, McMaster Childrens Hosp, Hamilton, ON, Canada
[2] Univ Toronto, Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5S 1A1, Canada
[3] Univ Toronto, Hosp Sick Children, Div Neurol, Dept Pediat, Toronto, ON M5S 1A1, Canada
[4] Univ Toronto, Hosp Sick Children, Dept Biostat, Toronto, ON M5S 1A1, Canada
[5] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat Neurol, Houston, TX 77030 USA
[6] Univ British Columbia, Dept Diagnost Imaging, Vancouver, BC V5Z 1M9, Canada
关键词
REVISED CRITERIA; CHILDREN; CLASSIFICATION; GUIDELINES; CONVERSION; CHILDHOOD; MS;
D O I
10.1212/01.wnl.0000338629.01627.54
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: MRI diagnostic criteria have not yet been adopted for pediatric multiple sclerosis (MS). MRI plays a pivotal role in supporting the diagnosis of MS in adults. We sought to quantitatively define the MRI features of pediatric MS, to determine features that distinguish MS from nondemyelinating relapsing childhood neurologic disorders, and to propose MRI criteria for lesion dissemination in space in children with MS. Methods: A retrospective analysis of MRI scans from 38 children with clinically definite MS and 45 children with nondemyelinating diseases with relapsing neurologic deficits (migraine, systemic lupus erythematosus) was performed. For each scan, T2/FLAIR hyperintense lesions were quantified and categorized according to location and size. Mean lesion counts in specific locations were compared between groups to derive diagnostic criteria. Validation of the proposed criteria was performed using MRI scans from a second independent MS cohort (n = 21). Results: MRI lesion location and size categories differed between children with MS and nondemyelinating controls with a medium to large effect size for most variables. The presence of at least two of the following-five or more lesions, two or more periventricular lesions, or one brainstem lesion-distinguished MS from other nondemyelinating disease controls with 85% sensitivity and 98% specificity. Conclusions: We propose modifications to the currently established McDonald MRI criteria for lesion dissemination in space that will enhance the diagnostic accuracy of these criteria for multiple sclerosis in children. Neurology (R) 2009; 72: 961-967
引用
收藏
页码:961 / 967
页数:7
相关论文
共 28 条
[1]   Long-term MRI observations of childhood-onset relapsing-remitting multiple sclerosis [J].
Balássy, C ;
Bernert, G ;
Wöber-Bingöl, C ;
Csapó, B ;
Kornek, B ;
Széles, J ;
Fleischmann, D ;
Prayer, D .
NEUROPEDIATRICS, 2001, 32 (01) :28-37
[2]   Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions [J].
Banwell, Brenda ;
Ghezzi, Angelo ;
Bar-Or, Amit ;
Mikaeloff, Yann ;
Tardieu, Marc .
LANCET NEUROLOGY, 2007, 6 (10) :887-902
[3]   Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis [J].
Barkhof, F ;
Filippi, M ;
Miller, DH ;
Scheltens, P ;
Campi, A ;
Polman, CH ;
Comi, G ;
Ader, HJ ;
Losseff, N ;
Valk, J .
BRAIN, 1997, 120 :2059-2069
[4]   Interobserver agreement for diagnostic MRI criteria in suspected multiple sclerosis [J].
Barkhof, F ;
Filippi, M ;
van Waesberghe, JHTM ;
Campi, A ;
Miller, DH ;
Adèr, HJ .
NEURORADIOLOGY, 1999, 41 (05) :347-350
[5]   Role of MRI in the differentiation of ADEM from MS in children [J].
Callen, D. J. A. ;
Shroff, M. M. ;
Branson, H. M. ;
Li, D. K. ;
Lotze, T. ;
Stephens, D. ;
Banwell, B. L. .
NEUROLOGY, 2009, 72 (11) :968-973
[6]  
Cohen J., 1988, Statistical Power Analysis for the Behavioral Sciences, V2nd, DOI [10.4324/9780203771587, DOI 10.4324/9780203771587]
[7]   Effect of early interferon treatment on conversion to definite multiple sclerosis:: a randomised study [J].
Comi, G ;
Filippi, M ;
Barkhof, F ;
Durelli, L ;
Edan, G ;
Fernández, O ;
Hartung, HP ;
Seeldrayers, P ;
Sorensen, PS ;
Rovaris, M ;
Martinelli, V ;
Hommes, OR .
LANCET, 2001, 357 (9268) :1576-1582
[8]   Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial [J].
Filippi, M ;
Rovaris, M ;
Inglese, M ;
Barkhof, F ;
De Stefano, N ;
Smith, S ;
Comi, G .
LANCET, 2004, 364 (9444) :1489-1496
[9]   Acquired inflammatory white matter diseases [J].
Gallucci, M ;
Caulo, M ;
Cerone, G ;
Masciocchi, C .
CHILDS NERVOUS SYSTEM, 2001, 17 (4-5) :202-210
[10]   Lesion distribution in children with clinically isolated syndromes [J].
Ghassemi, Rezwan ;
Antel, Samson B. ;
Narayanan, Sridar ;
Francis, Simon J. ;
Bar-Or, Amit ;
Sadovnick, A. Dessa ;
Banwell, Brenda ;
Arnold, Douglas L. .
ANNALS OF NEUROLOGY, 2008, 63 (03) :401-405